Bfsg, LLC Pharma Cyte Biotech, Inc. Transaction History
Bfsg, LLC
- $865 Million
- Q2 2025
A detailed history of Bfsg, LLC transactions in Pharma Cyte Biotech, Inc. stock. As of the latest transaction made, Bfsg, LLC holds 5 shares of PMCB stock, worth $4. This represents 0.0% of its overall portfolio holdings.
Number of Shares
5
Previous 5
-0.0%
Holding current value
$4
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding PMCB
# of Institutions
29Shares Held
662KCall Options Held
13.7KPut Options Held
2.1K-
Vanguard Group Inc Valley Forge, PA194KShares$163,3350.0% of portfolio
-
Geode Capital Management, LLC Boston, MA127KShares$106,3460.0% of portfolio
-
Ayrton Capital LLC Westport, CT92.1KShares$77,3537.31% of portfolio
-
Equitec Proprietary Markets, LLC82.7KShares$69,4900.09% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny49.8KShares$41,8320.0% of portfolio
About PharmaCyte Biotech, Inc.
- Ticker PMCB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 20,750,100
- Market Cap $17.4M
- Description
- PharmaCyte Biotech, Inc., a biotechnology company, focuses on developing and commercializing cellular therapies for cancer, diabetes, and malignant ascites in the United States. Its cellular therapies are developed based on Cell-in-a-Box, a proprietary cellulose-based live cell encapsulation technology used as a platform to treat various types o...